BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31174498)

  • 1. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex Characterization of Germline Large Genomic Rearrangements of the
    Bozsik A; Pócza T; Papp J; Vaszkó T; Butz H; Patócs A; Oláh E
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
    Rashid MU; Muhammad N; Amin A; Loya A; Hamann U
    Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
    Han E; Yoo J; Chae H; Lee S; Kim DH; Kim KJ; Kim Y; Kim M
    Clin Chim Acta; 2020 Jun; 505():49-54. PubMed ID: 32092317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements.
    Fachal L; Blanco A; Santamariña M; Carracedo A; Vega A
    PLoS One; 2014; 9(3):e93306. PubMed ID: 24686251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
    Silva FC; Lisboa BC; Figueiredo MC; Torrezan GT; Santos EM; Krepischi AC; Rossi BM; Achatz MI; Carraro DM
    BMC Med Genet; 2014 May; 15():55. PubMed ID: 24884479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features.
    James PA; Sawyer S; Boyle S; Young MA; Kovalenko S; Doherty R; McKinley J; Alsop K; Beshay V; Harris M; Fox S; Lindeman GJ; Mitchell G
    Fam Cancer; 2015 Jun; 14(2):287-95. PubMed ID: 25678442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer.
    Su L; Zhang J; Meng H; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Clin Genet; 2018 Jul; 94(1):165-169. PubMed ID: 29582426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
    El Ansari FZ; Jouali F; Marchoudi N; Bennani MM; Ghailani NN; Barakat A; Fekkak J
    BMC Cancer; 2020 Aug; 20(1):747. PubMed ID: 32778078
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kim DH; Cho CH; Kwon SY; Ryoo NH; Jeon DS; Lee W; Ha JS
    J Gynecol Oncol; 2018 Nov; 29(6):e90. PubMed ID: 30207098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.
    Santonocito C; Scapaticci M; Guarino D; Bartolini A; Minucci A; Concolino P; Scambia G; Paris I; Capoluongo E
    Breast; 2017 Dec; 36():74-78. PubMed ID: 29020660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
    McVeigh TP; Cody N; Carroll C; Duff M; Farrell M; Bradley L; Gallagher D; McDevitt T; Green AJ
    Cancer Genet; 2017 Aug; 214-215():1-8. PubMed ID: 28595730
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.
    van der Merwe NC; Oosthuizen J; Theron M; Chong G; Foulkes WD
    BMC Cancer; 2020 May; 20(1):391. PubMed ID: 32375709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.
    Sluiter MD; van Rensburg EJ
    Breast Cancer Res Treat; 2011 Jan; 125(2):325-49. PubMed ID: 20232141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome.
    Yoo J; Lee GD; Kim JH; Lee SN; Chae H; Han E; Kim Y; Kim M
    Ann Lab Med; 2020 Mar; 40(2):148-154. PubMed ID: 31650731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin.
    Ruiz de Garibay G; Gutiérrez-Enríquez S; Garre P; Bonache S; Romero A; Palomo L; Sánchez de Abajo A; Benítez J; Balmaña J; Pérez-Segura P; Díaz-Rubio E; Díez O; Caldés T; de la Hoya M
    Breast Cancer Res Treat; 2012 May; 133(1):273-83. PubMed ID: 22434521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
    Riahi A; Chabouni-Bouhamed H; Kharrat M
    Cancer Genet; 2017 Jan; 210():22-27. PubMed ID: 28212807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.